{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:31:05Z","timestamp":1787027465009,"version":"build-2736575974"},"reference-count":85,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Office of Research Infrastructure Programs of the National Institute of Health","award":["R21OD030057"],"award-info":[{"award-number":["R21OD030057"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease predominantly affecting elderly patients and carries significant morbidity and mortality. Patients typically suffer from severe itch with eczematous lesions, urticarial plaques, and\/or tense blisters. BP is characterized by the presence of circulating autoantibodies against two components of the hemidesmosome, BP180 and BP230. The transmembrane BP180, also known as type XVII collagen or BPAG2, represents the primary pathogenic autoantigen in BP, whereas the intracellular BP230 autoantigen is thought to play a minor role in disease pathogenesis. Although experimental data exist suggesting that anti-BP230 antibodies are secondarily formed following initial tissue damage mediated by antibodies targeting extracellular antigenic regions of BP180, there is emerging evidence that anti-BP230 IgG autoantibodies alone directly contribute to tissue damage. It has been further claimed that a subset of patients has a milder variant of BP driven solely by anti-BP230 autoantibodies. Furthermore, the presence of anti-BP230 autoantibodies might correlate with distinct clinical features. This review summarizes the current understanding of the role of BP230 and anti-BP230 antibodies in BP pathogenesis.<\/jats:p>","DOI":"10.3390\/antib11030044","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T03:16:06Z","timestamp":1656386166000},"page":"44","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid"],"prefix":"10.3390","volume":"11","author":[{"given":"Connor","family":"Cole","sequence":"first","affiliation":[{"name":"Division of Dermatology, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borradori","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Amber","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rush University Medical Center, Chicago, IL 60612, USA"},{"name":"Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Fontao","year":"2008","journal-title":"Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2018.5049","article-title":"Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid","volume":"155","author":"Kridin","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"680871","DOI":"10.3389\/fmed.2021.680871","article-title":"Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","article-title":"Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid","volume":"49","author":"Ishiura","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02505245","article-title":"The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen","volume":"288","author":"Matsumura","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG Autoantibodies from Bullous Pemphigoid Patients Recognize Multiple Antigenic Reactive Sites Located Predominantly Within the B and C Subdomains of the COOH-Terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Probst","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific Auto-Antibodies in Bullous Pemphigoid","volume":"122","author":"Uter","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.04630.x","article-title":"Evaluation of a New ELISA Assay for Detection of BP230 Autoantibodies in Bullous Pemphigoid","volume":"1173","author":"Tampoia","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: A retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clim.2012.02.003","article-title":"IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses","volume":"143","author":"Fania","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/A:1020531005776","article-title":"IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)","volume":"18","author":"Ghohestani","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1523-1747.ep12358276","article-title":"Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: A potential animal model for bullous pemphigoid","volume":"101","author":"Hall","year":"1993","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.09.007","article-title":"Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230","volume":"24","author":"Kiss","year":"2005","journal-title":"J. Autoimmun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17784","DOI":"10.1016\/S0021-9258(18)55195-4","article-title":"Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains","volume":"266","author":"Sawamura","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/S0021-9258(19)39844-8","article-title":"Structure of the human desmoplakins. Implications for function in the desmosomal plaque","volume":"265","author":"Green","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.114.1.83","article-title":"Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain with a three-domain structure based on a central alpha-helical coiled coil","volume":"114","author":"Wiche","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0959-437X(97)80154-2","article-title":"The plakin family: Versatile organizers of cytoskeletal architecture","volume":"7","author":"Ruhrberg","year":"1997","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1091\/mbc.e02-08-0548","article-title":"Interaction of the Bullous Pemphigoid Antigen 1 (BP230) and Desmoplakin with Intermediate Filaments Is Mediated by Distinct Sequences within Their COOH Terminus","volume":"14","author":"Fontao","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/excr.1997.3923","article-title":"Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes","volume":"239","author":"Borradori","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1083\/jcb.142.1.271","article-title":"Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1\/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180","volume":"142","author":"Schaapveld","year":"1998","journal-title":"J. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(95)90333-X","article-title":"Gene targeting of BPAG1: Abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration","volume":"81","author":"Guo","year":"1995","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200012098","article-title":"The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles","volume":"154","author":"Leung","year":"2001","journal-title":"J. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.yexcr.2006.04.025","article-title":"Dissecting the sequence specific functions of alternative N-terminal isoforms of mouse bullous pemphigoid antigen 1","volume":"312","author":"Jefferson","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Poliakova, K., Adebola, A., Leung, C.L., Favre, B., Liem, R.K.H., Schepens, I., and Borradori, L. (2014). BPAG1a and b associate with EB1 and EB3 and modulate vesicular transport, Golgi apparatus structure, and cell migration in C2.7 myoblasts. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107535"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.200410114","article-title":"Structural determinants for EB1-mediated recruitment of APC and spectraplakins to the microtubule plus end","volume":"168","author":"Slep","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/exd.12877","article-title":"One gene but different proteins and diseases: The complexity of dystonin and bullous pemphigoid antigen 1","volume":"25","author":"Kunzli","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/jid.2009.12","article-title":"Bullous Pemphigoid: A Prototypical Antibody-Mediated Organ-Specific Autoimmune Disease","volume":"129","author":"Sitaru","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J. Autoimmun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1172\/JCI119639","article-title":"A major role for neutrophils in experimental bullous pemphigoid","volume":"100","author":"Liu","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J. Investig. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1747.1999.00490.x","article-title":"Bullous Pemphigoid Sera that Contain Antibodies to BPAg2 also Contain Antibodies to LABD97 that Recognize Epitopes Distal to the NC16A Domain","volume":"112","author":"Egan","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.humimm.2014.01.005","article-title":"IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice","volume":"75","author":"Feldrihan","year":"2014","journal-title":"Hum. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jid.2020.08.031","article-title":"Autoantibodies to BPAG1e Trigger Experimental Bullous Pemphigoid in Mice","volume":"141","author":"Makita","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/bjd.15924","article-title":"IgE autoreactivity in bullous pemphigoid: Eosinophils and mast cells as major targets of pathogenic immune reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid","volume":"138","author":"Lin","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/1346-8138.15952","article-title":"BP230 IgE autoantibodies in topical-steroid-resistant bullous pemphigoid","volume":"48","author":"Shih","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","article-title":"Epitope spreading: Protection from pathogens, but propagation of autoimmunity?","volume":"26","author":"Powell","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Grosso","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of Epitope-Spreading Phenomena in Bullous Pemphigoid: Results of a Prospective Multicenter Study","volume":"131","author":"Calabresi","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/jid.2009.309","article-title":"Sequential Intramolecular Epitope Spreading of Humoral Responses to Human BPAG2 in a Transgenic Model","volume":"130","author":"Calabresi","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B Cells from Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP230","volume":"176","author":"Uter","year":"2006","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/1346-8138.13361","article-title":"Mucous membrane pemphigoid reactive only with BP230","volume":"43","author":"Inoue","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaad.2015.03.016","article-title":"Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases","volume":"73","author":"Ohata","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fmed.2018.00222","article-title":"Interaction of Psoriasis and Bullous Diseases","volume":"5","author":"Dainichi","year":"2018","journal-title":"Front. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjd.14821","article-title":"Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the USA","volume":"176","author":"Ren","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: A systematic review and meta-analysis","volume":"30","author":"Lai","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"37125","DOI":"10.1038\/srep37125","article-title":"Psychiatric and neurological disorders are associated with bullous pemphigoid\u2014A nationwide Finnish Care Register study","volume":"6","author":"Jokelainen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1590\/abd1806-4841.20142516","article-title":"Bullous pemphigoid and comorbidities: A case-control study in Portuguese patients","volume":"89","author":"Teixeira","year":"2014","journal-title":"An. Bras. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/jdv.17304","article-title":"Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti-BP230 seropositivity","volume":"35","author":"Stander","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/1871530318666180731115226","article-title":"Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?","volume":"18","author":"Petrera","year":"2018","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer\u2019s Disease","volume":"137","author":"Kokkonen","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/bjd.14538","article-title":"Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction","volume":"175","author":"Recke","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2133.2004.06338.x","article-title":"Bullous pemphigoid antigen 1 isoforms: Potential new target autoantigens in multiple sclerosis?","volume":"152","author":"Laffitte","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/ejn.12711","article-title":"Disruption of actin-binding domain-containing Dystonin protein causes dystonia musculorum in mice","volume":"40","author":"Horie","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09546630802683876","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: A retrospective analysis of 24 cases","volume":"20","author":"Sun","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archderm.1997.03890440133024","article-title":"Do anti-basement membrane zone antibodies cause some cases of \u2018senile pruritus\u2019?","volume":"133","author":"Bernhard","year":"1997","journal-title":"Arch. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-0960.2008.00452.x","article-title":"Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting","volume":"49","author":"Desai","year":"2008","journal-title":"Australas. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archderm.1996.03890340061010","article-title":"Serum from normal elderly individuals contains anti-basement membrane zone antibodies","volume":"132","author":"Hachisuka","year":"1996","journal-title":"Arch. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archdermatol.2009.331","article-title":"Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects","volume":"146","author":"Wieland","year":"2010","journal-title":"Arch. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamadermatol.2013.756","article-title":"Bullous pemphigoid as pruritus in the elderly: A common presentation","volume":"149","author":"Bakker","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2133.2009.09266.x","article-title":"IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses","volume":"161","author":"Feliciani","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1046\/j.1365-2133.2003.05603.x","article-title":"Diagnostic value of an enzyme-linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders","volume":"149","author":"Hofmann","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_79","first-page":"534","article-title":"Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus","volume":"18","author":"Jedlickova","year":"2008","journal-title":"Eur. J. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.1992.01680160075007","article-title":"Frequency of Bullous Pemphigoid\u2014like Antibodies as Detected by Western Immunoblot Analysis in Pruritic Dermatoses","volume":"128","year":"1992","journal-title":"Arch. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0151-9638(04)93611-3","article-title":"Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies","volume":"131","author":"Gary","year":"2004","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"569287","DOI":"10.3389\/fimmu.2021.569287","article-title":"Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients with Pruritic Disorders","volume":"12","author":"Didona","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/jdv.16996","article-title":"IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients","volume":"35","author":"Lamberts","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10972","article-title":"Bullous pemphigoid: An immune disorder related to aging (Review)","volume":"23","author":"Deotto","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII\/BP180","volume":"136","author":"Wada","year":"2016","journal-title":"J. Investig. Dermatol."}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/11\/3\/44\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:24Z","timestamp":1760139564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/11\/3\/44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["antib11030044"],"URL":"https:\/\/doi.org\/10.3390\/antib11030044","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]}}}